Trial studying safety and effects for Chronic Tinnitus
Official title Efficacy Analysis of Personalized-Target Transcranial Magnetic Stimulation (TMS) in the Treatment of Chronic Tinnitus: A Single-Center, Single-Blind Randomized Clinical Trial
ClinicalTrials.gov ID: NCT07267455
What this study is testing
- What it's testing
- This study is testing whether a brain‑stimulation that targets a person’s own hearing area works better than a standard target. It also looks at how safe the treatment is.
- Who it's for
- You may be able to join if you have been hearing ringing or buzzing in your ears for more than six months and you are not in a hurry to get a quick fix.
- What's involved
- You would receive a gentle magnetic pulse to the left side of your brain three times a day for five days. You will also fill out simple questionnaires about your ringing, anxiety, depression, and sleep before and after the treatment.
- Time commitment
- The study lasts about three months, with visits at the start, after the five‑day treatment, and again at one month and three months later for follow‑up checks.
Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 80
You may be able to join if
- 1.Patients with tinnitus as the main complaint: Patients perceive subjective sounds in the ears or deep within the skull in the absence of internal...
- 2.Patients with chronic tinnitus who meet the conditions including tinnitus duration of more than 6 months, THI (tinnitus handicap inventory) score ≥...
- 3.Outpatients of Sun Yat-sen University Sun Yat-sen Memorial Hospital who can receive continuous 5-day cTBS treatment.
- 4.Tinnitus frequency ranges from 125 Hz to 8000 Hz. 5.Aged 18-70 years.
You likely can't join if
- 1.Patients with tinnitus associated with the following conditions: conductive hearing loss, a history of middle ear surgery, pulsatile tinnitus...
- 2.A history of any of the following: head trauma, central nervous system diseases, psychiatric disorders, or substance abuse.
- 3.Pregnancy.
The study team makes the final eligibility decision.
Where it is enrolling
- Guangzhou, Guangdong, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Guangzhou, Guangdong, China. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.